Tempest Therapeutics (TPST)
(Real Time Quote from BATS)
$9.54 USD
-0.59 (-5.82%)
Updated Sep 22, 2025 02:08 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Tempest Therapeutics, Inc. has a market cap of $44.45M, which represents its share price of $10.01 multiplied by its outstanding shares number of 4.44M. As a small-cap company, TPST's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TPST 9.54 -0.59(-5.82%)
Will TPST be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TPST based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TPST
TPST Stock Up on EMA's Orphan Drug Tag for Liver Cancer Therapy
TPST to Evaluate Strategic Options for Pipeline Studies, Stock Up
TPST: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TPST
Directional Movement Crossover Bullish appears for TPST after 1.2% move
TPST rises 4.49% on September 19, leaving the technical picture intact
Directional Movement Crossover Bearish appears for TPST after 4.87% move
TPST's price rises by 1.51% on September 16, though its technical setup remains stable.
20 Day Moving Average Resistance appears for TPST after 3.27% move